NCT04662463

Brief Summary

The primary objective of this study is to examine the effects of cognitive bias modification for interpretation (CBM-I) on prenatal anxiety in parturients. Half of the participants will receive CBM-I assignments, while the other half will receive placebo assignments.

Trial Health

45
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
6mo left

Started Sep 2024

Typical duration for not_applicable anxiety

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Sep 2024Dec 2026

First Submitted

Initial submission to the registry

July 31, 2018

Completed
2.4 years until next milestone

First Posted

Study publicly available on registry

December 10, 2020

Completed
3.7 years until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 13, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

July 31, 2018

Last Update Submit

May 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Effects of Internet-Based Cognitive Bias Modification (CBM-I) on prenatal anxiety

    Change in State-Trait Anxiety Inventory (STAI) scores before and after the CBM-I assignment.

    4 weeks (starting from 36-week gestation)

Study Arms (2)

CBM-I assignment

EXPERIMENTAL

Patients will receive CBM-I assignments

Behavioral: Cognitive Bias Modification for Interpretation (CBM-I)

Placebo assignment

PLACEBO COMPARATOR

Patients will receive placebo assignments

Behavioral: Placebo

Interventions

Patients will receive CBM-I training by reading and imaging themselves in a series of emotionally ambiguous scenarios. Each scenario ends with an incomplete final word. Patients need to complete the final word to resolve the scenario in a positive direction.

CBM-I assignment
PlaceboBEHAVIORAL

Patients will receive placebo task which uses neutral rather than emotional material.

Placebo assignment

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsParturients only
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-45
  • Women before 36-week gestation
  • At least high school level education

You may not qualify if:

  • They refuse
  • Have impaired decision-making capacity
  • Are blind or extremely visually impaired (excluding use of glasses)
  • Cannot understand or read English
  • Diagnosed with psychiatric disorder other than anxiety

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Lester KJ, Field AP, Muris P. Experimental modification of interpretation bias about animal fear in young children: effects on cognition, avoidance behavior, anxiety vulnerability, and physiological responding. J Clin Child Adolesc Psychol. 2011;40(6):864-77. doi: 10.1080/15374416.2011.618449.

    PMID: 22023278BACKGROUND
  • Bowler JO, Mackintosh B, Dunn BD, Mathews A, Dalgleish T, Hoppitt L. A comparison of cognitive bias modification for interpretation and computerized cognitive behavior therapy: effects on anxiety, depression, attentional control, and interpretive bias. J Consult Clin Psychol. 2012 Dec;80(6):1021-33. doi: 10.1037/a0029932. Epub 2012 Sep 10.

  • O'Connor TG, Ben-Shlomo Y, Heron J, Golding J, Adams D, Glover V. Prenatal anxiety predicts individual differences in cortisol in pre-adolescent children. Biol Psychiatry. 2005 Aug 1;58(3):211-7. doi: 10.1016/j.biopsych.2005.03.032.

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Jie Zhou, MD, MS, MBA

    Harvard Medical School (HMS and HSDM)

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 31, 2018

First Posted

December 10, 2020

Study Start

September 1, 2024

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 13, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share